Cefazolin: Clinical Trials

5 trials of Cefazolin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Unknown 5

Follow Cefazolin: new trials by email Literature Review of Cefazolin trials Research Report on Cefazolin

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
Cefazolin 1000 MG - Antibiotic Prophylaxis, Wound Infection
Phase 3UnknownUniversity of Aleppo2002024-08-012024-08-28
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline - Staphylococcus Aureus Bacteremia
Phase 3UnknownClinical Research Centre, Malaysia2902024-06-282024-07-05
Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen.
Cefazolin - Infection Prosthesis Hip and Knee, Infection, Prosthesis Related
Phase 3UnknownRadboud University Medical Center7512019-01-012024-05-07
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
Cefazolin - Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis Catheter Infection
Phase 3UnknownCarmel Medical Center2002017-03-082023-02-13
Preventive Antibiotic Serum Levels During Caesarean Section
Blood samples., Cefazolin - Blood Antibiotic Levels
Phase 3UnknownTel-Aviv Sourasky Medical Center2502016-08-012016-07-20

Conditions studied

Surgical Wound Infection (2)  ·  Bacteremia (1)  ·  Hernia, Inguinal (1)  ·  Postoperative Complications (1)  ·  Prosthesis-Related Infections (1)  ·  Staphylococcal Infections (1)  ·  Wound Infection (1)

Sponsors

Carmel Medical Center (1)  ·  Clinical Research Centre, Malaysia (1)  ·  Radboud University Medical Center (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of Aleppo (1)

Countries

Israel (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Syria (1)

Top investigators

Bart-Jan Kullberg, prof. Dr (1)  ·  Victor Frajewicki, MD (1)  ·  Yariv Yogev, professor (1)